Fractalkine Polyclonal Antibody

The soluble form is chemotactic for T-cells and monocytes, but not for neutrophils. The membrane-bound form promotes adhesion of those leukocytes to endothelial cells. May play a role in regulating leukocyte adhesion and migration processes at the endothelium. Binds to CX3CR1.

The Fractalkine Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Fractalkine protein in various biological samples. This antibody is produced using advanced recombinant DNA technology, ensuring high purity and batch-to-batch consistency.

Fractalkine, also known as CX3CL1, is a chemokine protein that plays a crucial role in immune response and inflammation. It is expressed on the surface of endothelial cells and neurons, acting as both a chemoattractant and an adhesion molecule. The Fractalkine Polyclonal Antibody recognizes the extracellular domain of Fractalkine, allowing for precise and reliable detection of this protein.

This antibody has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and flow cytometry. It exhibits excellent specificity, showing minimal cross-reactivity with other related chemokines. Furthermore, it demonstrates high sensitivity, enabling the detection of low levels of Fractalkine protein in complex biological samples.

The Fractalkine Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size and concentration, allowing for easy customization and optimization of experimental conditions. Each batch is rigorously quality controlled to ensure consistent performance and reliability.

In summary, the Fractalkine Polyclonal Antibody is a valuable tool for researchers studying the role of Fractalkine in various biological processes. Its high specificity, sensitivity, and reliability make it an essential component of any Fractalkine-related research project.